| __timestamp | BioMarin Pharmaceutical Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 461543000 | 15635076 |
| Thursday, January 1, 2015 | 634806000 | 23943601 |
| Friday, January 1, 2016 | 661905000 | 23689111 |
| Sunday, January 1, 2017 | 610753000 | 41006114 |
| Monday, January 1, 2018 | 696328000 | 51379106 |
| Tuesday, January 1, 2019 | 715007000 | 32705593 |
| Wednesday, January 1, 2020 | 628116000 | 53274000 |
| Friday, January 1, 2021 | 628793000 | 85352000 |
| Saturday, January 1, 2022 | 649606000 | 51999000 |
| Sunday, January 1, 2023 | 746773000 | 59471000 |
| Monday, January 1, 2024 | 747184000 |
In pursuit of knowledge
In the competitive landscape of biotechnology, research and development (R&D) investments are crucial for innovation and growth. Over the past decade, BioMarin Pharmaceutical Inc. has consistently outpaced Summit Therapeutics Inc. in R&D spending. From 2014 to 2023, BioMarin's R&D expenses grew by approximately 62%, peaking in 2023. In contrast, Summit Therapeutics saw a more modest increase of around 280% over the same period, reflecting its smaller scale and different strategic focus.
BioMarin's substantial investment, averaging over $640 million annually, underscores its commitment to pioneering treatments for rare diseases. Meanwhile, Summit's focused approach, with an average annual spend of about $44 million, highlights its strategic targeting of niche markets. This divergence in investment strategies offers a fascinating glimpse into how these companies navigate the challenges and opportunities within the biotech sector.
Research and Development Investment: Novo Nordisk A/S vs Summit Therapeutics Inc.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Summit Therapeutics Inc.
Comparing Innovation Spending: Summit Therapeutics Inc. and Madrigal Pharmaceuticals, Inc.
Analyzing R&D Budgets: Summit Therapeutics Inc. vs Corcept Therapeutics Incorporated
Research and Development: Comparing Key Metrics for Summit Therapeutics Inc. and Rhythm Pharmaceuticals, Inc.
R&D Insights: How Summit Therapeutics Inc. and PTC Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Summit Therapeutics Inc. and Travere Therapeutics, Inc.
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Alkermes plc
BioMarin Pharmaceutical Inc. or Lantheus Holdings, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Taro Pharmaceutical Industries Ltd.
Research and Development Investment: BioMarin Pharmaceutical Inc. vs Travere Therapeutics, Inc.
BioMarin Pharmaceutical Inc. or Evotec SE: Who Invests More in Innovation?